Stada Plans IPO for Autumn If Market Conditions Favorable
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 28 2025
0mins
Should l Buy CON?
Source: WSJ
Stada's IPO Plans: Private-equity backed Stada is planning to launch an initial public offering (IPO) this fall after postponing it in the spring.
Reason for Delay: The German pharmaceutical company delayed its IPO due to geopolitical uncertainty and market volatility.
Industry Context: Stada is not alone; other companies like StubHub and Klarna also postponed their IPOs earlier this year, influenced by U.S. President Trump's tariff policies.
Market Trends: There is a growing queue of companies looking to list before the end of the year, indicating a potential shift in market conditions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CON?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CON
Wall Street analysts forecast CON stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 23.890
Low
27.00
Averages
28.67
High
30.00
Current: 23.890
Low
27.00
Averages
28.67
High
30.00
About CON
Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. It delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care, to more than 50,000 patients each day, on average, from about 620 occupational health centers in 41 states and 160 onsite health clinics at employer worksites in 36 states. Its Occupational Health Centers segment encompasses the services it delivers at its occupational health center facilities across the United States. Its Onsite Health Clinics segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services. Its Other Businesses segment comprises several complementary services to its core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy and Concentra Medical Compliance Administration.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Concentra Releases Preliminary Financial Results for FY 2025
- Significant Revenue Growth: For FY 2025, Concentra expects revenue to reach $2.1634 billion, a 13.9% increase from $1.9002 billion in FY 2024, indicating strong market demand and business expansion capabilities in the occupational health services sector.
- Substantial Net Income Increase: The anticipated net income for FY 2025 is $172.8 million, slightly up from $171.9 million in FY 2024, reflecting ongoing improvements in cost control and operational efficiency.
- Record Patient Visits: In FY 2025, patient visits are projected to total 13,546,707, averaging 53,124 visits per day, which is a 7.7% increase from 49,311 visits per day in FY 2024, demonstrating success in enhancing customer service and market penetration.
- Optimistic 2026 Outlook: Concentra forecasts revenue for 2026 to be between $2.25 billion and $2.35 billion, with adjusted EBITDA expected to be between $450 million and $470 million, showcasing confidence in future growth and effective strategic planning.
See More
Continental Meets Full-Year Sales Targets, Advances ContiTech Sale
- Sales Performance Achieved: Continental reported approximately €19.7 billion in sales for fiscal 2025, aligning with its guidance range of €19.5 billion to €21 billion, demonstrating stability despite market challenges.
- Strong Tyres Division: The tyres business generated around €3.6 billion in sales for Q4, with full-year sales expected at €13.8 billion and an adjusted EBIT margin projected at 13.6%, reflecting positive mix effects and cost optimizations.
- ContiTech Challenges: Despite overall strong performance, ContiTech's profitability fell short of expectations, with Q4 sales anticipated at around €1.4 billion and full-year sales at approximately €6 billion, indicating a persistently weak market environment.
- Sale Plan Progressing: Continental is advancing its plan to divest ContiTech by 2026, having completed internal preparations and concluded the market outreach phase, with a structured sales process set to begin this month, indicating strong market interest in the division's value.
See More
Concentra Opens New Medical Center in Hialeah, Florida to Enhance Service Capacity
- New Medical Center Opening: Concentra has opened a new medical center in Hialeah, Florida, located at 855 East 8th Avenue, aiming to optimize its service capabilities in the region to better meet the health needs of employers and employees.
- Expanded Service Offerings: The new center will provide work injury care, physical therapy, drug testing, and DOT physical exams, further enhancing Concentra's market position in Florida by offering comprehensive occupational health services.
- Telemedicine Services: Through the Concentra Telemed® platform, the center will also offer telemedicine for minor work injuries, enabling employees to conveniently access medical support when needed, thereby improving service accessibility.
- Strengthened National Network: With over 625 locations nationwide, this expansion not only reinforces Concentra's presence in Florida but also enables the company to more effectively meet the growing demand for comprehensive occupational health services in the region.
See More
Concentra Opens New Medical Center in Corona, California
- New Medical Center Opening: Concentra has opened a new medical center in Corona, California, located at 629 North Main Street, Unit C-3, aimed at expanding access to care for local employers and employees, thereby increasing its market share in California.
- Comprehensive Service Offering: The new center will provide work injury care, physical therapy, drug testing, DOT physical exams, and other employer-related health services, addressing the growing demand for occupational health services in the region and enhancing the company's competitive edge in the industry.
- Telemedicine Availability: Concentra will also offer telemedicine services for minor work injuries through its proprietary Concentra Telemed® platform, which not only improves service accessibility but also enhances customer satisfaction and loyalty.
- National Network Expansion: With over 625 locations nationwide, this expansion further solidifies Concentra's position as the largest provider of occupational health services in the U.S., expected to deliver efficient medical care to over 50,000 patients daily.
See More
Concentra Names Jason Cooper as Chief Officer for Data, Analytics, and Artificial Intelligence
Appointment of Jason Cooper: Concentra has appointed Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer to align the company's data strategy with growth priorities.
Expertise and Experience: Cooper brings over 25 years of experience in data and technology across various sectors, including roles at L3-Communications, CVS Caremark, and Cigna.
Focus on Data-Driven Outcomes: Cooper aims to enhance Concentra's data governance and AI initiatives, building on the company's established reputation as an innovator in occupational health services.
Concentra's Mission: As the largest provider of occupational health services in the U.S., Concentra serves over 50,000 patients daily through its extensive network of health centers and clinics.
See More
Chips Previously Stalled by Trade War Begin to Reach Auto Suppliers Again
Nexperia Microchips: Nexperia microchips are being shipped from China, helping to alleviate a shortage of essential components for the automotive industry.
Aumovio's Role: Aumovio, a new automotive supplier spun off from Continental, is receiving these semiconductors at its distribution hub in Hungary.
See More
Concentra Releases Preliminary Financial Results for FY 2025
- Significant Revenue Growth: For FY 2025, Concentra expects revenue to reach $2.1634 billion, a 13.9% increase from $1.9002 billion in FY 2024, indicating strong market demand and business expansion capabilities in the occupational health services sector.
- Substantial Net Income Increase: The anticipated net income for FY 2025 is $172.8 million, slightly up from $171.9 million in FY 2024, reflecting ongoing improvements in cost control and operational efficiency.
- Record Patient Visits: In FY 2025, patient visits are projected to total 13,546,707, averaging 53,124 visits per day, which is a 7.7% increase from 49,311 visits per day in FY 2024, demonstrating success in enhancing customer service and market penetration.
- Optimistic 2026 Outlook: Concentra forecasts revenue for 2026 to be between $2.25 billion and $2.35 billion, with adjusted EBITDA expected to be between $450 million and $470 million, showcasing confidence in future growth and effective strategic planning.
See More
Continental Meets Full-Year Sales Targets, Advances ContiTech Sale
- Sales Performance Achieved: Continental reported approximately €19.7 billion in sales for fiscal 2025, aligning with its guidance range of €19.5 billion to €21 billion, demonstrating stability despite market challenges.
- Strong Tyres Division: The tyres business generated around €3.6 billion in sales for Q4, with full-year sales expected at €13.8 billion and an adjusted EBIT margin projected at 13.6%, reflecting positive mix effects and cost optimizations.
- ContiTech Challenges: Despite overall strong performance, ContiTech's profitability fell short of expectations, with Q4 sales anticipated at around €1.4 billion and full-year sales at approximately €6 billion, indicating a persistently weak market environment.
- Sale Plan Progressing: Continental is advancing its plan to divest ContiTech by 2026, having completed internal preparations and concluded the market outreach phase, with a structured sales process set to begin this month, indicating strong market interest in the division's value.
See More
Concentra Opens New Medical Center in Hialeah, Florida to Enhance Service Capacity
- New Medical Center Opening: Concentra has opened a new medical center in Hialeah, Florida, located at 855 East 8th Avenue, aiming to optimize its service capabilities in the region to better meet the health needs of employers and employees.
- Expanded Service Offerings: The new center will provide work injury care, physical therapy, drug testing, and DOT physical exams, further enhancing Concentra's market position in Florida by offering comprehensive occupational health services.
- Telemedicine Services: Through the Concentra Telemed® platform, the center will also offer telemedicine for minor work injuries, enabling employees to conveniently access medical support when needed, thereby improving service accessibility.
- Strengthened National Network: With over 625 locations nationwide, this expansion not only reinforces Concentra's presence in Florida but also enables the company to more effectively meet the growing demand for comprehensive occupational health services in the region.
See More
Concentra Opens New Medical Center in Corona, California
- New Medical Center Opening: Concentra has opened a new medical center in Corona, California, located at 629 North Main Street, Unit C-3, aimed at expanding access to care for local employers and employees, thereby increasing its market share in California.
- Comprehensive Service Offering: The new center will provide work injury care, physical therapy, drug testing, DOT physical exams, and other employer-related health services, addressing the growing demand for occupational health services in the region and enhancing the company's competitive edge in the industry.
- Telemedicine Availability: Concentra will also offer telemedicine services for minor work injuries through its proprietary Concentra Telemed® platform, which not only improves service accessibility but also enhances customer satisfaction and loyalty.
- National Network Expansion: With over 625 locations nationwide, this expansion further solidifies Concentra's position as the largest provider of occupational health services in the U.S., expected to deliver efficient medical care to over 50,000 patients daily.
See More
Concentra Names Jason Cooper as Chief Officer for Data, Analytics, and Artificial Intelligence
Appointment of Jason Cooper: Concentra has appointed Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer to align the company's data strategy with growth priorities.
Expertise and Experience: Cooper brings over 25 years of experience in data and technology across various sectors, including roles at L3-Communications, CVS Caremark, and Cigna.
Focus on Data-Driven Outcomes: Cooper aims to enhance Concentra's data governance and AI initiatives, building on the company's established reputation as an innovator in occupational health services.
Concentra's Mission: As the largest provider of occupational health services in the U.S., Concentra serves over 50,000 patients daily through its extensive network of health centers and clinics.
See More
Chips Previously Stalled by Trade War Begin to Reach Auto Suppliers Again
Nexperia Microchips: Nexperia microchips are being shipped from China, helping to alleviate a shortage of essential components for the automotive industry.
Aumovio's Role: Aumovio, a new automotive supplier spun off from Continental, is receiving these semiconductors at its distribution hub in Hungary.
See More
